Laura Gieldon
Oldenburg, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.
Journal: Med (New York, N.Y.)
Published: July 27, 2025
Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.
Journal: Med (New York, N.Y.)
Published: September 04, 2024
Case Report: Heterozygous ADAR c.3019G>A pathogenic variant associated with variable neurological symptoms and incomplete penetrance in a four-generational family.
Journal: Frontiers in immunology
Published: June 23, 2024
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 06, 2022
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
Journal: Genes, chromosomes & cancer
Published: May 22, 2021
Acute Stanford type B aortic dissection-who benefits from genetic testing?
Journal: Journal of thoracic disease
Published: December 07, 2020
Germ cell mosaicism for AUTS2 exon 6 deletion.
Journal: American journal of medical genetics. Part A
Published: September 28, 2020
Correction: Diagnostic value of partial exome sequencing in developmental disorders.
Journal: PloS one
Published: September 24, 2020
Germline testing for homologous recombination repair genes-opportunities and challenges.
Journal: Genes, chromosomes & cancer
Published: August 21, 2020
Last Updated: 09/26/2026